1288 related articles for article (PubMed ID: 17403839)
1. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
Wu CL; Yang YC; Huang LM; Chen KT
Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
[TBL] [Abstract][Full Text] [Related]
3. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
4. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
[TBL] [Abstract][Full Text] [Related]
6. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
7. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of a rotavirus immunization program for the United States.
Smith JC; Haddix AC; Teutsch SM; Glass RI
Pediatrics; 1995 Oct; 96(4 Pt 1):609-15. PubMed ID: 7567319
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
Tate JE; Rheingans RD; O'Reilly CE; Obonyo B; Burton DC; Tornheim JA; Adazu K; Jaron P; Ochieng B; Kerin T; Calhoun L; Hamel M; Laserson K; Breiman RF; Feikin DR; Mintz ED; Widdowson MA
J Infect Dis; 2009 Nov; 200 Suppl 1():S76-84. PubMed ID: 19817618
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of a rotavirus immunization program for the United States.
Tucker AW; Haddix AC; Bresee JS; Holman RC; Parashar UD; Glass RI
JAMA; 1998 May; 279(17):1371-6. PubMed ID: 9582045
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
[TBL] [Abstract][Full Text] [Related]
15. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
16. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
Shim E; Galvani AP
Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
[TBL] [Abstract][Full Text] [Related]
17. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
18. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
[TBL] [Abstract][Full Text] [Related]
19. An economic analysis of rotavirus vaccination in Italy.
Giammanco MD; Coniglio MA; Pignato S; Giammanco G
Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934
[TBL] [Abstract][Full Text] [Related]
20. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
